0001806540-20-000001.txt : 20200317
0001806540-20-000001.hdr.sgml : 20200317
20200317135137
ACCESSION NUMBER: 0001806540-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200317
DATE AS OF CHANGE: 20200317
EFFECTIVENESS DATE: 20200317
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lycia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001806540
IRS NUMBER: 843860514
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-363038
FILM NUMBER: 20720402
BUSINESS ADDRESS:
STREET 1: 6175 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-224-7766
MAIL ADDRESS:
STREET 1: 6175 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
D
1
primary_doc.xml
X0708
D
LIVE
0001806540
Lycia Therapeutics, Inc.
6175 NANCY RIDGE DRIVE
SAN DIEGO
CA
CALIFORNIA
92121
858-224-7766
DELAWARE
None
None
Corporation
true
2019
Jeremy
S.
Caldwell
6175 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Clare
Ozawa
6175 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Director
Thomas
Woiwode
6175 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Director
Laurent
Fischer
6175 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-03-03
false
true
false
1
50390410
25390410
25000000
false
1
0
0
0
false
Lycia Therapeutics, Inc.
/s/ Jeremy S. Caldwell
Jeremy S. Caldwell
Chief Executive Officer
2020-03-17